Cargando…
The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma – a Swedish population-based study
BACKGROUND: Comorbidity increases overall mortality in patients diagnosed with hematological malignancies. The impact of comorbidity on cancer-specific mortality, taking competing risks into account, has not been evaluated. METHODS: Using the Swedish Cancer Register, we identified patients aged >...
Autores principales: | Mohammadi, Mohammad, Cao, Yang, Glimelius, Ingrid, Bottai, Matteo, Eloranta, Sandra, Smedby, Karin E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634819/ https://www.ncbi.nlm.nih.gov/pubmed/26537111 http://dx.doi.org/10.1186/s12885-015-1857-x |
Ejemplares similares
-
Family history of colorectal cancer and survival: a Swedish population‐based study
por: Pesola, F., et al.
Publicado: (2020) -
Clinical characteristics and outcomes among 2347 patients aged ≥85 years with major lymphoma subtypes: a Nordic Lymphoma Group study
por: Wästerlid, Tove, et al.
Publicado: (2020) -
P081: Treatment-related circulatory diseases and mortality in Hodgkin lymphoma patients using multi-state modelling and relative survival
por: Baech, Joachim, et al.
Publicado: (2022) -
No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study
por: Frisk, Gabriella, et al.
Publicado: (2018) -
Nationwide Assessment of Patient Trajectories in Mantle Cell Lymphoma: The Swedish MCLcomplete Project
por: Jerkeman, Mats, et al.
Publicado: (2023)